Zbären Peter, Nuyens Michel, Loosli Heinz, Stauffer Edouard
Department of Otolaryngology, Head and Neck Surgery, University of Berne, Inselspital, Berne, Switzerland.
Cancer. 2004 May 1;100(9):1876-83. doi: 10.1002/cncr.20186.
The low incidence and histologic heterogeneity of primary parotid carcinomas makes it difficult to evaluate the value of preoperative fine-needle aspiration cytology (FNAC) and intraoperative frozen section (FS) analysis. In the current study, the authors reviewed a single institution's experience regarding the preoperative and intraoperative diagnostic value of FNAC and FS in primary salivary gland carcinomas.
Between January 1990 and December 2002, 108 primary parotid carcinomas were resected at the Department of Otorhinolaryngology, Head and Neck Surgery at the University of Berne, Inselspital (Berne, Switzerland). Included in the study were a total of 101 carcinomas with preoperative FNAC results in 88 tumors and/or intraoperative FS results in 45 tumors. In a retrospective study, the results of FNAC and FS were analyzed and compared with the corresponding histopathologic diagnoses.
The cytologic findings were true-positive for malignancy in 63 tumors (72%), false-negative in 22 tumors (25%), and nondiagnostic in 3 tumors (3%). The tumor grading was correct in 29 of 63 tumors (46%), and the exact tumor typing was correct in 27 of 63 (43%) true-positive tumors. The FS findings were true-positive for malignancy in 43 of 45 tumors (96%), the tumor grading was correct in 35 of 45 tumors (78%), and the tumor typing was correct in 32 of 45 tumors (71%). Overall, at the time of surgery, of the 101 parotid carcinomas, the tumor was known to be malignant in 83 tumors (82%), and the correct grade and the exact tumor type were known in 55 tumors (54%) and 48 tumors (48%), respectively.
FNAC recognized malignancy in 72% of tumors, but it could not be relied upon to provide an accurate tumor grading or typing. Therefore, FNAC alone is not prone to determine the surgical management of primary parotid carcinomas. The current analysis showed the statistically significant superiority of FS compared with FNAC regarding the diagnosis of malignancy, tumor grading, and tumor typing in primary parotid carcinomas.
原发性腮腺癌的发病率较低且组织学异质性较大,这使得评估术前细针穿刺细胞学检查(FNAC)和术中冰冻切片(FS)分析的价值变得困难。在本研究中,作者回顾了单一机构关于FNAC和FS在原发性涎腺癌中的术前和术中诊断价值的经验。
1990年1月至2002年12月期间,瑞士伯尔尼因塞尔医院耳鼻咽喉头颈外科共切除108例原发性腮腺癌。纳入研究的共有101例癌,其中88例肿瘤有术前FNAC结果,45例肿瘤有术中FS结果。在一项回顾性研究中,分析了FNAC和FS的结果,并与相应的组织病理学诊断进行比较。
细胞学检查结果显示,63例肿瘤(72%)为恶性真阳性,22例肿瘤(25%)为假阴性,3例肿瘤(3%)为未明确诊断。63例肿瘤中有29例(46%)肿瘤分级正确,63例(43%)恶性真阳性肿瘤中有27例确切肿瘤类型正确。FS检查结果显示,45例肿瘤中有43例(96%)为恶性真阳性,45例肿瘤中有35例(78%)肿瘤分级正确,45例肿瘤中有32例(71%)肿瘤类型正确。总体而言,在手术时,101例腮腺癌中,83例肿瘤(82%)已知为恶性,55例肿瘤(54%)和48例肿瘤(48%)分别已知正确分级和确切肿瘤类型。
FNAC在72%的肿瘤中识别出恶性,但它不能可靠地提供准确的肿瘤分级或类型。因此,仅FNAC不易确定原发性腮腺癌的手术治疗方案。目前的分析表明,在原发性腮腺癌的恶性诊断、肿瘤分级和肿瘤类型方面,FS与FNAC相比具有统计学上的显著优势。